Kezar Life Sciences Inc (KZR)
0.914
+0.01
(+1.51%)
USD |
NASDAQ |
Mar 28, 15:01
Kezar Life Sciences Price to Book Value: 0.3548 for March 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 27, 2024 | 0.3495 |
March 26, 2024 | 0.3469 |
March 25, 2024 | 0.3551 |
March 22, 2024 | 0.3782 |
March 21, 2024 | 0.3745 |
March 20, 2024 | 0.3464 |
March 19, 2024 | 0.338 |
March 18, 2024 | 0.3378 |
March 15, 2024 | 0.3416 |
March 14, 2024 | 0.3299 |
March 13, 2024 | 0.3532 |
March 12, 2024 | 0.361 |
March 11, 2024 | 0.3702 |
March 08, 2024 | 0.3711 |
March 07, 2024 | 0.388 |
March 06, 2024 | 0.3997 |
March 05, 2024 | 0.3997 |
March 04, 2024 | 0.3958 |
March 01, 2024 | 0.3997 |
February 29, 2024 | 0.4074 |
February 28, 2024 | 0.4035 |
February 27, 2024 | 0.3762 |
February 26, 2024 | 0.3477 |
February 23, 2024 | 0.3493 |
February 22, 2024 | 0.3298 |
Date | Value |
---|---|
February 21, 2024 | 0.3232 |
February 20, 2024 | 0.3207 |
February 16, 2024 | 0.3259 |
February 15, 2024 | 0.3272 |
February 14, 2024 | 0.3266 |
February 13, 2024 | 0.3229 |
February 12, 2024 | 0.3414 |
February 09, 2024 | 0.3698 |
February 08, 2024 | 0.3676 |
February 07, 2024 | 0.3616 |
February 06, 2024 | 0.3655 |
February 05, 2024 | 0.3622 |
February 02, 2024 | 0.3668 |
February 01, 2024 | 0.3686 |
January 31, 2024 | 0.3839 |
January 30, 2024 | 0.3555 |
January 29, 2024 | 0.3595 |
January 26, 2024 | 0.3219 |
January 25, 2024 | 0.3185 |
January 24, 2024 | 0.3123 |
January 23, 2024 | 0.3182 |
January 22, 2024 | 0.3238 |
January 19, 2024 | 0.322 |
January 18, 2024 | 0.3259 |
January 17, 2024 | 0.3414 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2414
Minimum
Nov 10 2023
7.280
Maximum
Dec 30 2021
1.797
Average
1.680
Median
Price to Book Value Benchmarks
Tonix Pharmaceuticals Holding Corp | 0.1162 |
NovaBay Pharmaceuticals Inc | 0.1352 |
Palatin Technologies Inc | -- |
iBio Inc | 1.610 |
Theriva Biologics Inc | 0.1978 |
Price to Book Value Related Metrics
Price | 0.914 |
Earnings Yield | -154.3% |
Market Cap | 66.54M |